Novo Nordisk is one of the few highly reputed pharma businesses and there is a reason for it. Rather than stick to its economistic origins that so many of its competitors live and organize by, Novo Nordisk allowed itself to experiment and react to stakeholder criticism. Rather than reactively...

10.2 trillion dollars have been lost in the US alone in the past two years. 45% of world’s wealth has been destroyed and three of the largest bankruptcies in the US have occurred in the past year. Just as the majority of observers thought lessons from Enron had been learned, crisis has struck...

In this paper we explore the question of corporate governance and its connection with CSR.We outline why a traditional governance architecture (e.g. unitary board structures) fails to support monitoring and strategic advice functions concerning CSR of the board adequately. We then provide our...